ARCHIVES

OMB Reprogramming Ban Criticized

This article is from The Cancer Letter archive.

Vol. 11 No. 36 | September 20, 1985

Download PDF Visit The Full Archive

Related Articles

Pooled Analysis of Two LUX-Lung Trials Shows Prolonged Survival with Afatinib

June 27, 2014

Includes May Business & Regulatory Report (8-page issue).

June 6, 2003

DeVita Denies NCI Broke Faith With Communities On CHOP Awards, Says Total Of 30 “Not Absolute”

August 15, 1980

Weight An Indicator For Risk Of Developing Myeloma

August 31, 2007

Spartanburg CCOP Makes the List

April 10, 1987

NCI Advisory Group, Other Cancer Meetings

April 29, 1983